Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126522661 | 12652266 | 1 | I | 20151216 | 20160810 | 20160815 | 20160815 | EXP | FR-ABBVIE-16P-056-1699487-00 | ABBVIE | 44.88 | YR | F | Y | 68.00000 | KG | 20160815 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126522661 | 12652266 | 1 | PS | NORVIR | RITONAVIR | 1 | Oral | Y | UNKNOWN | 20945 | |||||||||
| 126522661 | 12652266 | 2 | SS | MALOCIDE | PYRIMETHAMINE | 1 | Unknown | Y | 0 | ||||||||||
| 126522661 | 12652266 | 3 | SS | ADIAZINE | SULFADIAZINE | 1 | Oral | Y | 0 | ||||||||||
| 126522661 | 12652266 | 4 | SS | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Oral | SHORT-TERM | Y | 0 | |||||||||
| 126522661 | 12652266 | 5 | SS | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Oral | Y | 0 | ||||||||||
| 126522661 | 12652266 | 6 | SS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | Oral | Y | 0 | ||||||||||
| 126522661 | 12652266 | 7 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126522661 | 12652266 | 1 | HIV infection |
| 126522661 | 12652266 | 2 | Toxoplasmosis |
| 126522661 | 12652266 | 3 | Toxoplasmosis |
| 126522661 | 12652266 | 4 | Product used for unknown indication |
| 126522661 | 12652266 | 5 | Product used for unknown indication |
| 126522661 | 12652266 | 6 | HIV infection |
| 126522661 | 12652266 | 7 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126522661 | 12652266 | LT |
| 126522661 | 12652266 | OT |
| 126522661 | 12652266 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126522661 | 12652266 | Cholestasis | |
| 126522661 | 12652266 | Drug reaction with eosinophilia and systemic symptoms | |
| 126522661 | 12652266 | Eosinophilia | |
| 126522661 | 12652266 | Face oedema | |
| 126522661 | 12652266 | Hepatocellular injury | |
| 126522661 | 12652266 | Hepatomegaly | |
| 126522661 | 12652266 | Leukocytosis | |
| 126522661 | 12652266 | Lung infection | |
| 126522661 | 12652266 | Pyrexia | |
| 126522661 | 12652266 | Rash maculo-papular |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126522661 | 12652266 | 1 | 20151209 | 20151218 | 0 | |
| 126522661 | 12652266 | 2 | 20151118 | 20151221 | 0 | |
| 126522661 | 12652266 | 3 | 20151118 | 20151221 | 0 | |
| 126522661 | 12652266 | 4 | 20151129 | 20151227 | 0 | |
| 126522661 | 12652266 | 5 | 20151129 | 20151227 | 0 | |
| 126522661 | 12652266 | 6 | 20151209 | 20151218 | 0 | |
| 126522661 | 12652266 | 7 | 20151209 | 20151221 | 0 |